O-acetyl-GD2 ganglioside

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Birklé, Stéphane: 3 articles (01/2017 - 01/2011)
2.	Cochonneau, Denis: 3 articles (01/2017 - 01/2011)
3.	Paris, François: 3 articles (01/2017 - 01/2011)
4.	Alvarez-Rueda, Nidia: 2 articles (06/2013 - 01/2011)
5.	Aubry, Jacques: 2 articles (06/2013 - 01/2011)
6.	Bougras, Gwenola: 2 articles (06/2013 - 01/2011)
7.	Bahri, Meriem: 1 article (01/2017)
8.	Clémenceau, Béatrice: 1 article (01/2017)
9.	Fleurence, Julien: 1 article (01/2017)
10.	Fougeray, Sophie: 1 article (01/2017)

1.	Neoplasms (Cancer) 01/01/2017 - "Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy." 01/01/2011 - "A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity." 06/10/2013 - "O-Acetyl-GD2 ganglioside is suitable antigen for tumor immunotherapy with specific therapeutic antibody. "

1.	Immunotherapy